Invention Grant
- Patent Title: Imidazo[4,5-c] ring compounds containing guanidine substituted benzamide groups
-
Application No.: US16471632Application Date: 2018-02-27
-
Publication No.: US10766896B2Publication Date: 2020-09-08
- Inventor: Bryon A. Merrill , George W. Griesgraber , Chad A. Haraldson , Kevin J. Bechtold
- Applicant: 3M INNOVATIVE PROPERTIES COMPANY
- Applicant Address: US MN St. Paul
- Assignee: 3M INNOVATIVE PROPERTIES COMPANY
- Current Assignee: 3M INNOVATIVE PROPERTIES COMPANY
- Current Assignee Address: US MN St. Paul
- Agent Eric E. Silverman
- International Application: PCT/US2018/019922 WO 20180227
- International Announcement: WO2018/160552 WO 20180907
- Main IPC: C07D471/04
- IPC: C07D471/04
![Imidazo[4,5-c] ring compounds containing guanidine substituted benzamide groups](/abs-image/US/2020/09/08/US10766896B2/abs.jpg.150x150.jpg)
Abstract:
Imidazo[4,5-c] ring compounds of formula I, (particularly imidazo4,5-c]quinolines, 6,7,8,9-tetrahydroimidazo[4,5-c]quinolines, imidazo[4,5-c]naphthyridines, and 6,7,8,9-tetrahydroimidazo[4,5-c]naphthyridine compounds) having a guanidine substituted benzamide that is attached at the N−1 position by a linking group, pharmaceutical compositions containing the compounds, and methods of making the compounds are disclosed. Methods of use of the compounds as immune response modifiers, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are also disclosed.
Public/Granted literature
- US20200087298A1 Imidazo[4,5-c] Ring Compounds Containing Guanidine Substituted Benzamide Groups Public/Granted day:2020-03-19
Information query